Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides

Strength Training for PCOS: The Insulin Mechanism and a Starting Programme

9 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

Skeletal muscle handles roughly 80% of insulin-stimulated glucose uptake in the body, which is why resistance training changes insulin sensitivity through a route cardio does not. PCOS-specific trials running 10 weeks to 4 months show real but mixed results: strength gains and lower testosterone are consistent; insulin-resistance improvement is not guaranteed without added cardio.

Why skeletal muscle is the mechanism that actually matters

About 80% of insulin-stimulated glucose uptake in the human body happens inside skeletal muscle, according to the clamp studies underlying modern understanding of insulin resistance. Every set of resistance work forces the trained muscle to take up glucose to refuel itself, and repeating that stress over weeks increases how much glucose the same muscle can clear the next time insulin rises — a structural change in tissue, not a temporary calorie deficit. Cardio improves insulin sensitivity too, largely through a different pathway tied to mitochondrial and cardiovascular adaptation, which is why the two are complementary rather than interchangeable. This is the mechanism behind several PCOS symptoms tied to insulin resistance, and it is the reason resistance training belongs in a PCOS plan even without a single pound of change on a scale.

Mechanically, a muscle contraction pulls glucose transporters (GLUT4) to the cell surface through a pathway that does not need insulin at all, so the muscle can clear glucose from the blood during and immediately after a session regardless of how insulin-resistant the rest of the body is. Doing that repeatedly increases both the number of these transporters at rest and the muscle’s capacity to store glucose as glycogen — the structural adaptation that shows up weeks later as a lower fasting glucose or a better HOMA-IR score on a lab test.

Common concerns about lifting weights with PCOS

Lifting weights will not make a woman “bulky” without a training volume and, usually, a hormonal environment far beyond what any of the trials below used — three sessions a week for four months produced strength and lean-mass gains, not a visible size change beyond what most people would call “toned.” A second common worry runs the other way: that PCOS’s higher androgen levels make joints or tendons more injury-prone under load. No trial cited here reported an elevated injury rate in its PCOS participants compared with non-PCOS participants training the same protocol, and the standard precautions — a controlled warm-up, adding load only once form is solid — apply equally to everyone starting a new lifting programme.

What the PCOS-specific trials actually found

Four trials specifically in women with PCOS have tested resistance training’s effects, and they do not all agree — which is the honest starting point rather than a marketing one.

Table 1 — resistance-training trials in women with PCOS.
TrialProtocolDurationKey result
Kogure et al. 2016 (n=45 PCOS, 52 non-PCOS)Progressive resistance training, 3×/week4 monthsTestosterone and fasting glucose fell; lean mass and muscle mass index rose; no broader metabolic-panel change
Kogure et al. 2018 (same cohort)Same protocol, strength tested at 8 and 16 weeks4 monthsMax strength rose on bench press and leg extension (p=0.04); body fat % fell in both PCOS and non-PCOS groups
Almenning et al. 2015 (n=31)Strength training vs interval training vs control, 3×/week10 weeksStrength arm: anti-Müllerian hormone fell 14.8 pmol/L; HOMA-IR improved only in the interval-training arm, not strength
Vizza et al. 2016 (n=15, pilot)2 supervised + 2 home sessions/week12 weeksWaist circumference and HbA1c improved vs control; body weight and lean mass both rose

Two consistent findings run through all four: strength itself goes up reliably, and testosterone or a related androgen marker moves in a favourable direction in the trials that measured it. What is not consistent is insulin resistance measured directly as HOMA-IR — the 10-week trial found it improved only with interval training, not strength training alone — which is the honest reason a PCOS training week should not drop cardio entirely in favour of lifting.

Worth naming plainly: these are small trials, 15 to 97 participants each, run over 10 weeks to 4 months, and two of the four share the same cohort of 45 women. That is real evidence, not proof at scale — enough to justify strength training as part of a PCOS routine, not enough to promise a specific number on a lab test by a specific week. Larger, longer replication would sharpen these estimates; until it exists, these four trials are what the recommendation below is built on.

Do women with PCOS build muscle faster than other women?

No trial has shown PCOS causes faster muscle growth, but one trial found something more specific: women with higher androgen levels gained maximum strength on the bench press and leg extension at a rate independent of how much their body composition changed, per a 2018 trial specifically testing that relationship. Higher testosterone is one input into strength adaptation — it does not blunt the response to training the way some assume, and in this cohort it did not slow it either. It is not a licence to expect dramatic size gains without the training volume that produces them in anyone: the same trial’s 45 PCOS participants trained three times a week for four months to get their result, and both the PCOS and non-PCOS groups in that trial gained lean mass and strength at a broadly similar pace.

A beginner strength programme built on what these trials actually did

Every trial above ran resistance training two to three times a week for 10 to 16 weeks before reporting a result, so that is the minimum commitment worth planning around rather than a single month.

  1. Weeks 1–4 — learn the five movements. Squat, hip hinge, push, pull, and a core or carry exercise, 2–3 sessions a week, 2–3 sets of 10–12 reps at a weight where the last 2 reps feel effortful but controlled. This mirrors the 8-week initial phase used before the strength tests in the Kogure trials.
  2. Weeks 5–8 — add load, not volume. Once every set at the current weight feels controlled for all reps, add the smallest available weight increase rather than more sets. This is where the trials above started registering measurable strength gains on the same lifts.
  3. Weeks 9–12 — add a third weekly session if recovery allows. Vizza’s trial ran 2 supervised plus 2 home sessions a week for 12 weeks and still saw a significant HbA1c improvement — a third session is additive, not mandatory, for a result inside three months.

What changes, and on what realistic timeline

Strength on specific lifts is the fastest-moving marker, showing up by 8 weeks in trials that tested it at that point; body composition markers such as waist circumference and body fat percentage follow at 10–12 weeks; and hormonal markers such as testosterone take the full 4 months some trials ran to register a significant change. If the single outcome you care about is insulin resistance specifically, expect strength training alone to move it more slowly and less reliably than adding an interval-training or cardio component, based on the one trial that measured HOMA-IR directly and found no significant change in the strength-only arm.

Who this will not work for

Strength training will not be the fastest lever if HOMA-IR or a fasting insulin number is the specific marker you are trying to move — the trial evidence points to interval or aerobic work doing that more reliably, with strength training as the complement rather than the lead. It also will not substitute for medical management of hyperandrogenism severe enough to need medication, and it is not a safe starting point without modification for anyone with an unassessed joint injury, a hernia, or uncontrolled blood pressure, all of which need a clinician’s input before loaded lifting.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same androgen and insulin mechanisms this article is built around — only the label changed. This article uses PCOS, since that is still what most readers search.

This programme is one half of a full week — the complete weekly structure, including where cardio and rest days fit around these strength sessions, is laid out in our PCOS workout plan, and if session timing is a question, the evidence on morning versus evening training is covered separately. Both sit inside the wider movement, sleep and stress levers this site covers for PCOS.

Common questions

  • Does lifting weights raise testosterone in women with PCOS?

    No — the trials above found the opposite effect. Two separate resistance-training trials in women with PCOS reported testosterone falling significantly after roughly 4 months of consistent training, alongside improvements in body fat percentage, rather than testosterone rising as some assume heavier lifting might cause.
  • Can strength training help with PCOS-related muscle gain if I am also lean?

    Yes. The trials cited here ranged from 15 to 97 participants across a BMI range of 18 to 39.9, and strength and lean-mass gains were not limited to any one body size — a lean-PCOS phenotype responded to the same progressive resistance protocol as a higher-BMI phenotype did.
  • How many sets and reps should a beginner with PCOS start with?

    Two to three sets of 10 to 12 reps per movement, at a weight where the last two reps feel effortful but controlled, matches the loading used in the trials that reported measurable strength and body-composition results within 8 to 12 weeks.
  • Is strength training safe with PCOS and high androgens?

    Yes — none of the four trials above reported an adverse event linked to resistance training in their PCOS participants, and one trial specifically found testosterone fell rather than rose over the 4-month training period, with no elevated injury rate versus non-PCOS participants.
  • Will strength training alone fix my insulin resistance?

    Not reliably on its own. One 10-week trial found insulin resistance, measured as HOMA-IR, improved by 17% only in the interval-training group and not in the strength-training group, which is the specific reason pairing the two performs better than relying on strength training alone.

Your next step

Book three weekly slots for the next four weeks, learn the five movements at a controlled weight, and do not add load until every rep in every set stops feeling uncertain. The trials behind this programme did not require more than that to produce their results — just repetition of a simple structure for longer than a single month.

More on this

Sources

  1. 1.DeFronzo RA, Tripathy D. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care. 2009.
  2. 2.Kogure GS, Miranda-Furtado CL, Silva RC, et al. Resistance Exercise Impacts Lean Muscle Mass in Women With Polycystic Ovary Syndrome. Med Sci Sports Exerc. 2016.
  3. 3.Kogure GS, Silva RC, Miranda-Furtado CL, et al. Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome. J Strength Cond Res. 2018.
  4. 4.Almenning I, Rieber-Mohn A, Lundgren KM, et al. Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women With Polycystic Ovary Syndrome: A Pilot Study. PLoS One. 2015.
  5. 5.Vizza L, Smith CA, Swaraj S, et al. The Feasibility of Progressive Resistance Training in Women With Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial. BMC Sports Sci Med Rehabil. 2016.
  6. 6.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.